Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,298 | 0 |
| Depreciation Amortization | 1 | 0 |
| Accounts payable and accrued liabilities | 247 | N/A |
| Other Working Capital | 220 | 0 |
| Other Operating Activity | 101 | 0 |
| Operating Cash Flow | $-729 | $0 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $0 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 14,963 | 0 |
| Financing Cash Flow | $14,963 | $0 |
| Beginning Cash Position | 4,207 | 0 |
| End Cash Position | 18,441 | 0 |
| Net Cash Flow | $14,234 | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | -729 | 0 |
| Free Cash Flow | -729 | 0 |